Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arcadia Biosciences (RKDA) Loans and Notes Receivables (2024 - 2025)

Arcadia Biosciences (RKDA) has disclosed Loans and Notes Receivables for 2 consecutive years, with $2.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Loans and Notes Receivables changed N/A year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Mar 2025, changed N/A, and an annual FY2024 reading of $1.9 million, changed N/A over the prior year.
  • Loans and Notes Receivables was $2.0 million for Q1 2025 at Arcadia Biosciences, up from $1.9 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $2.0 million in Q1 2025 and bottomed at $1.8 million in Q2 2024.